Labetalol HCL
- Product NDC
- 70934-913
- 11-digit product format
- 709340913
- Labeler code
- 70934
- Product ID
- 70934-913_ce3cb14f-cb13-f6e1-e053-2a95a90a9aa6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Labetalol Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA200908
- Marketing category
- ANDA
- Marketing start
- 2021-10-12
- Marketing end
- 0000-00-00
- Substance
- LABETALOL HYDROCHLORIDE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 1GEV3BAW9J | LABETALOL HYDROCHLORIDE | 32780-64-6 | LABETALOL HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-913-60 | 70934091360 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-913-60) | 2021-10-12 | 0000-00-00 | No | No | Current |